NCT05923333View on ClinicalTrials.gov

B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 11, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
HivVaccine ReactionMicrobial ColonizationInfant Development
Interventions
DIETARY_SUPPLEMENT

B. infantis Rosell®-33

B. infantis Rosell®-33 + maltodextrin

DIETARY_SUPPLEMENT

Placebo

Maltodextrin

Trial Locations (1)

Unknown

RECRUITING

Khayelitsha Site B Midwife Obstetric Unit, Cape Town

Sponsors
All Listed Sponsors
collaborator

Seattle Children's Hospital

OTHER

collaborator

University of Stellenbosch

OTHER

collaborator

Institute for Systems Biology

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

University of Washington

OTHER

lead

University of Cape Town

OTHER